journal
MENU ▼
Read by QxMD icon Read
search

European Urology

journal
https://www.readbyqxmd.com/read/28216172/re-jean-pierre-droz-gilles-albrand-silke-gillessen-et-al-management-of-prostate-cancer-in-elderly-patients-recommendations-of-a-task-force-of-the-international-society-of-geriatric-oncology-eur-urol-in-press-http-dx-doi-org-10-1016-j-eururo-2016-12-025-health
#1
LETTER
https://www.readbyqxmd.com/read/28214034/reply-to-pascal-mouracade-s-letter-to-the-editor-re-giorgio-gandaglia-nicola-fossati-armando-stabile-et-al-radical-prostatectomy-in-men-with-oligometastatic-prostate-cancer-results-of-a-single-institution-series-with-long-term-follow-up-eur-urol-in-press-http
#2
LETTER
https://www.readbyqxmd.com/read/28214033/reply-to-salvador-vale-s-letter-to-the-editor-re-cesare-cozzarini-whole-pelvis-radiotherapy-in-the-radiation-treatment-of-intermediate-and-high-risk-prostate-cancer-how-to-improve-the-therapeutic-ratio-of-a-potentially-effective-but-still-unsatisfactory-treatment
#3
LETTER
https://www.readbyqxmd.com/read/28214032/picking-on-fibroblast-growth-factor-receptors-as-bladder-cancer-therapeutic-targets
#4
EDITORIAL
Miriam Marqués, Francisco X Real
No abstract text is available yet for this article.
February 14, 2017: European Urology
https://www.readbyqxmd.com/read/28214031/the-impact-of-histological-variants-of-urothelial-carcinoma-on-clinical-outcomes-following-trimodality-bladder-sparing-chemoradiation
#5
EDITORIAL
Anne E Kiltie, Lisa Browning
No abstract text is available yet for this article.
February 14, 2017: European Urology
https://www.readbyqxmd.com/read/28214030/re-cesare-cozzarini-whole-pelvis-radiotherapy-in-the-radiation-treatment-of-intermediate-and-high-risk-prostate-cancer-how-to-improve-the-therapeutic-ratio-of-a-potentially-effective-but-still-unsatisfactory-treatment-eur-urol-2017-71-44-5-preclinical-combinatorial
#6
LETTER
https://www.readbyqxmd.com/read/28209431/corrigendum-re-serum-levels-of-microrna-mir-371a-3p-a-sensitive-and-specific-new-biomarker-for-germ-cell-tumours-eur-urol-2017-71-213-20
#7
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, Thomas Balks, Cord Matthies, Pascal Becker, Christian Ruf, Christoph Oing, Karin Oechsle, Carsten Bokemeyer, Johannes Hammel, Sebastian Melchior, Werner Wosniok, Gazanfer Belge
No abstract text is available yet for this article.
February 13, 2017: European Urology
https://www.readbyqxmd.com/read/28196724/persistence-and-adherence-with-mirabegron-versus-antimuscarinic-agents-in-patients-with-overactive-bladder-a-retrospective-observational-study-in-uk-clinical-practice
#8
Christopher R Chapple, Jameel Nazir, Zalmai Hakimi, Sally Bowditch, Francis Fatoye, Florent Guelfucci, Amine Khemiri, Emad Siddiqui, Adrian Wagg
BACKGROUND: Persistence with antimuscarinic therapy in overactive bladder (OAB) is poor, but may be different for mirabegron, a β3-adrenoceptor agonist with a different adverse event profile. OBJECTIVE: To compare persistence and adherence with mirabegron versus tolterodine extended release (ER) and other antimuscarinics in routine clinical practice over a 12-mo period. DESIGN, SETTING, AND PARTICIPANTS: Retrospective, longitudinal, observational study of anonymised data from the UK Clinical Practice Research Datalink GOLD database...
February 11, 2017: European Urology
https://www.readbyqxmd.com/read/28196723/diagnostic-performance-of-prostate-imaging-reporting-and-data-system-version-2-for-detection-of-prostate-cancer-a-systematic-review-and-diagnostic-meta-analysis
#9
REVIEW
Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim
CONTEXT: In 2015, the updated Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) for the detection of prostate cancer (PCa) was established. Since then, several studies assessing the value of PI-RADSv2 have been published. OBJECTIVE: To review the diagnostic performance of PI-RADSv2 for the detection of PCa. EVIDENCE ACQUISITION: MEDLINE and EMBASE databases were searched up to December 7, 2016. We included diagnostic accuracy studies that used PI-RADSv2 for PCa detection, using prostatectomy or biopsy as the reference standard...
February 11, 2017: European Urology
https://www.readbyqxmd.com/read/28189430/how-reliable-are-trial-based-prognostic-models-in-real-world-patients-with-metastatic-castration-resistant-prostate-cancer
#10
LETTER
Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, Outi Hirvonen, Tarja Laitinen, Sirkku Jyrkkiö, Laura L Elo
No abstract text is available yet for this article.
February 8, 2017: European Urology
https://www.readbyqxmd.com/read/28189429/regular-aspirin-use-and-the-risk-of-lethal-prostate-cancer-in-the-physicians-health-study
#11
Mary K Downer, Christopher B Allard, Mark A Preston, J Michael Gaziano, Meir J Stampfer, Lorelei A Mucci, Julie L Batista
BACKGROUND: Regular aspirin use probably protects against some malignancies including prostate cancer (PC), but its impact on lethal PC is particularly unclear. OBJECTIVE: To investigate the association between regular aspirin and (1) the risk of lethal PC in a large prospective cohort and (2) survival after PC diagnosis. DESIGN, SETTING, AND PARTICIPANTS: In 1981/82, the Physicians' Health Study randomized 22 071 healthy male physicians to aspirin, β-carotene, both, or placebo...
February 8, 2017: European Urology
https://www.readbyqxmd.com/read/28189428/adjuvant-and-salvage-radiotherapy-after-radical-prostatectomy-in-prostate-cancer-patients
#12
Giorgio Gandaglia, Alberto Briganti, Noel Clarke, R Jeffrey Karnes, Markus Graefen, Piet Ost, Anthony Laurence Zietman, Mack Roach
CONTEXT: Prostate cancer (PCa) patients found to have adverse pathologic features following radical prostatectomy (RP) are less likely to be cured with surgery alone. OBJECTIVE: To analyze the role of postoperative radiotherapy (RT) in patients with aggressive PCa. EVIDENCE ACQUISITION: We performed a systematic literature review of the Medline and EMBASE databases. The search strategy included the terms radical prostatectomy, adjuvant radiotherapy, and salvage radiotherapy, alone or in combination...
February 8, 2017: European Urology
https://www.readbyqxmd.com/read/28185688/partial-nephrectomy-for-large-or-complex-masses-option-or-obsolete
#13
EDITORIAL
Ithaar H Derweesh, Riccardo Autorino, Karim Bensalah, Umberto Capitanio
No abstract text is available yet for this article.
February 6, 2017: European Urology
https://www.readbyqxmd.com/read/28169017/re-alessandro-morlacco-john-c-cheville-laureano-j-rangel-derek-j-gearman-r-jeffrey-karnes-adverse-disease-features-in-gleason-score-3-4-favorable-intermediate-risk-prostate-cancer-implications-for-active-surveillance-eur-urol-in-press-http-dx-doi-org-10-1016
#14
LETTER
https://www.readbyqxmd.com/read/28169016/from-gleason-grading-system-and-high-grade-tertiary-patterns-to-grade-groups-and-integrated-quantitative-gleason-score
#15
EDITORIAL
Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Antonio Lopez-Beltran
No abstract text is available yet for this article.
February 3, 2017: European Urology
https://www.readbyqxmd.com/read/28162817/re-efficacy-and-safety-of-tadalafil-5mg-once-daily-in-the-treatment-of-lower-urinary-tract-symptoms-associated-with-benign-prostatic-hyperplasia-in-men-aged-%C3%A2-75-years-integrated-analyses-of-pooled-data-from-multinational-randomized-placebo-controlled-clinical
#16
https://www.readbyqxmd.com/read/28162816/active-surveillance-discussion-for-low-risk-prostate-cancer-patients-preferences-and-counseling-techniques
#17
EDITORIAL
Ardalan E Ahmad, Antonio Finelli
No abstract text is available yet for this article.
February 2, 2017: European Urology
https://www.readbyqxmd.com/read/28162815/improving-the-rotterdam-european-randomized-study-of-screening-for-prostate-cancer-risk-calculator-for-initial-prostate-biopsy-by-incorporating-the-2014-international-society-of-urological-pathology-gleason-grading-and-cribriform-growth
#18
Monique J Roobol, Jan F M Verbeek, Theo van der Kwast, Intan P Kümmerlin, Charlotte F Kweldam, Geert J L H van Leenders
BACKGROUND: The survival rate for men with International Society of Urological Pathology (ISUP) grade 2 prostate cancer (PCa) without invasive cribriform (CR) and intraductal carcinoma (IDC) is similar to that for ISUP grade 1. If updated into the European Randomized Study of Screening for Prostate Cancer (ERSPC Rotterdam) risk calculator number 3 (RC3), this may further improve upfront selection of men who need a biopsy. OBJECTIVE: To improve the number of possible biopsies avoided, while limiting undiagnosed clinically important PCa by applying the updated RC3 for risk-based patient selection...
February 2, 2017: European Urology
https://www.readbyqxmd.com/read/28161029/reply-to-runqiang-yuan-and-hongxing-huang-s-letter-to-the-editor-re-ernesto-r-cordeiro-feijoo-arjun-sivaraman-eric-barret-et-al-focal-high-intensity-focused-ultrasound-targeted-hemiablation-for-unilateral-prostate-cancer-a-prospective-evaluation-of-oncologic
#19
LETTER
https://www.readbyqxmd.com/read/28153447/re-functional-outcomes-after-transurethral-resection-of-the-prostate-in-nursing-home-residents
#20
Stephan Madersbacher
No abstract text is available yet for this article.
January 30, 2017: European Urology
journal
journal
20110
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"